Drug Facts

Drug Facts
SPL v1
SPL
SPL Set ID 3cc80bdc-214d-3d1b-e054-00144ff88e88
Route
TOPICAL
Published
Effective Date 2016-08-26
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Hyaluronic Acid (6.1 g)
Inactive Ingredients
Water Madecassoside Lactose

Identifiers & Packaging

Marketing Status
UNAPPROVED DRUG OTHER Active Since 2016-08-01
Description

Sodium Hyaluronate

Medication Information

Warnings and Precautions

1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).



1) Occurrence of red spots, swelling, itchiness, and other skin irritation



2) If the symptoms above occur after the application area is exposed to direct sunlight



2. Do not use on open wounds, eczema, and other skin irritations



3. Precaution for Storage and Handling



1) Close the lid after use



2) Keep out of reach of infants and children



3) Do not to store in a place with high/low temperature and exposed to direct sunlight

4. Use as avoiding eye areas.

Indications and Usage
  • Apply DEEPAIR MICRO INTENSIVE MAGIC CREAM before attaching the patches.
  • Open the pouch.
  • Remove the films.
  • Attach the patches around the eye areas.
  • Pat firm.
  • Leave it for more than 30 minutes.
Dosage and Administration

for external use only



Description

Sodium Hyaluronate

Section 50565-1

keep out of reach of the children

Section 51727-6

Water, Acetyl Octapeptide-3, Caprylyl Glycol, Madecassoside, Lactose

Section 51945-4

Section 55105-1

Skin Protectant

Section 55106-9

Sodium Hyaluronate

Structured Label Content

Indications and Usage (34067-9)
  • Apply DEEPAIR MICRO INTENSIVE MAGIC CREAM before attaching the patches.
  • Open the pouch.
  • Remove the films.
  • Attach the patches around the eye areas.
  • Pat firm.
  • Leave it for more than 30 minutes.
Dosage and Administration (34068-7)

for external use only



Warnings and Precautions (34071-1)

1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).



1) Occurrence of red spots, swelling, itchiness, and other skin irritation



2) If the symptoms above occur after the application area is exposed to direct sunlight



2. Do not use on open wounds, eczema, and other skin irritations



3. Precaution for Storage and Handling



1) Close the lid after use



2) Keep out of reach of infants and children



3) Do not to store in a place with high/low temperature and exposed to direct sunlight

4. Use as avoiding eye areas.

Section 50565-1 (50565-1)

keep out of reach of the children

Section 51727-6 (51727-6)

Water, Acetyl Octapeptide-3, Caprylyl Glycol, Madecassoside, Lactose

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

Skin Protectant

Section 55106-9 (55106-9)

Sodium Hyaluronate

Advanced Ingredient Data

Raw Label Data

All Sections (JSON)

Additional Information

Back to search View SPL set listing Open on DailyMed ↗

Source: dailymed · Ingested: 2026-02-15T11:56:10.213010 · Updated: 2026-03-14T22:54:26.235755